Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-17-041664
Filing Date
2017-11-09
Accepted
2017-11-09 06:06:13
Documents
55
Period of Report
2017-11-09

Document Format Files

Seq Description Document Type Size
1 6-K form6k.htm 6-K 19520
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 461826
9 image00001.jpg GRAPHIC 4321
  Complete submission text file 0001140361-17-041664.txt   2579581

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT bysi-20170930.xml EX-101.INS 394918
4 XBRL TAXONOMY EXTENSION SCHEMA bysi-20170930.xsd EX-101.SCH 39862
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bysi-20170930_cal.xml EX-101.CAL 32972
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bysi-20170930_def.xml EX-101.DEF 244421
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bysi-20170930_lab.xml EX-101.LAB 182447
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bysi-20170930_pre.xml EX-101.PRE 258605
Mailing Address 28 LIBERTY STREET 39TH FLOOR NEW YORK NY 10005
Business Address 28 LIBERTY STREET 39TH FLOOR NEW YORK NY 10005 646-528-4184
BeyondSpring Inc. (Filer) CIK: 0001677940 (see all company filings)

EIN.: 463009483 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38024 | Film No.: 171188121
SIC: 2834 Pharmaceutical Preparations